HEI Stock Analysis: Heico | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 41.435m USD | 12M Return: -2.9% | US4228061093 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 151M
EPS Trend: 99.8%
Qual. Beats: 7
Rev. Trend: 98.8%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HEICO Corporation is a U.S.-based industrial company operating in the aerospace, defense, and electronics sectors through two business segments. The Flight Support Group supplies jet engine and aircraft replacement parts, thermal insulation products, and a wide range of hydraulic, pneumatic, structural, and electromechanical components, while also providing repair and overhaul services for aircraft parts, avionics, instruments, and military aircraft systems. The Electronic Technologies Group produces electro-optical infrared simulation and test equipment, RF and microwave products, power electronics, specialty semiconductors, antennas, communications receivers, and radiation detection equipment, among other components.
The company serves commercial, regional, general aviation, and military customers across the United States and internationally, and is classified within the Industrials sector under the Aerospace & Defense sub-industry. HEICOs dual-segment structure - combining parts distribution and MRO services with higher-technology electronic components - is a common model in the aerospace aftermarket, where suppliers support both original equipment manufacturers and existing fleets. The company was incorporated in 1957, is headquartered in Hollywood, Florida, and has been listed on the NYSE since 1992.
- Commercial aviation aftermarket recovery drives Flight Support revenue growth
- Defense electronics demand lifts Electronic Technologies Group margins
- Serial acquisitions expand niche aerospace and defense product portfolio
| Net Income: 847.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.20 > 1.0 |
| NWC/Revenue: 33.27% < 20% (prev 39.04%; Δ -5.77% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.11b > Net Income 847.7m |
| Net Debt (2.33b) to EBITDA (1.47b): 1.59 < 3 |
| Current Ratio: 2.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (141.3m) vs 12m ago 0.23% < -2% |
| Gross Margin: 40.40% > 18% (prev 41.48%; Δ -1.08% > 0.5%) |
| Asset Turnover: 56.06% > 50% (prev 50.28%; Δ 5.79% > 0%) |
| Interest Coverage Ratio: 9.44 > 6 (EBIT TTM 1.25b / Interest Expense TTM 132.4m) |
| A: 0.17 (Total Current Assets 2.73b - Total Current Liabilities 1.00b) / Total Assets 9.94b |
| B: 0.42 (Retained Earnings 4.22b / Total Assets 9.94b) |
| C: 0.14 (EBIT TTM 1.25b / Avg Total Assets 9.23b) |
| D: 1.15 (Book Value of Equity 4.95b / Total Liabilities 4.29b) |
| Altman-Z'' = 4.64 = AA |
| DSRI: 0.99 (Receivables 870.8m/730.6m, Revenue 5.18b/4.29b) |
| GMI: 1.03 (GM 41.48% / 40.40%) |
| AQI: 1.01 (AQ_t 0.68 / AQ_t-1 0.67) |
| SGI: 1.21 (Revenue 5.18b / 4.29b) |
| TATA: -0.03 (NI 847.7m - CFO 1.11b) / TA 9.94b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at USD 308.53 with a total of 615,896 shares traded. Over the past week, the price has changed by +3.46%, over one month by -12.11%, over three months by -9.87% and over the past year by -2.89%.
Current recommended Stop Loss: 291.00 (which is 5.7% or 2 ATR below the current price).
Heico has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy HEI.
- StrongBuy: 9
- Buy: 4
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 394 | 27.7% |
P/E Trailing = 49.9966
P/E Forward = 41.1523
P/S = 8.0041
P/B = 8.458
P/EG = 2.0568
Revenue TTM = 5.18b USD
EBIT TTM = 1.25b USD
EBITDA TTM = 1.47b USD
Long Term Debt = 2.54b USD (from longTermDebt, last quarter)
Short Term Debt = 3.51m USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter) + Leases 25.7m
Net Debt = 2.33b USD (calculated: Debt 2.57b - CCE 241.0m)
Enterprise Value = 43.8b USD (41.4b + Debt 2.57b - CCE 241.0m)
Interest Coverage Ratio = 9.44 (Ebit TTM 1.25b / Interest Expense TTM 132.4m)
EV/FCF = 42.48x (Enterprise Value 43.8b / FCF TTM 1.03b)
FCF Yield = 2.35% (FCF TTM 1.03b / Enterprise Value 43.8b)
FCF Margin = 19.90% (FCF TTM 1.03b / Revenue TTM 5.18b)
Net Margin = 16.38% (Net Income TTM 847.7m / Revenue TTM 5.18b)
Gross Margin = 40.40% ((Revenue TTM 5.18b - Cost of Revenue TTM 3.09b) / Revenue TTM)
Gross Margin QoQ = 41.12% (prev 41.40%)
Tobins Q-Ratio = 4.40 (Enterprise Value 43.8b / Total Assets 9.94b)
Interest Expense / Debt = 5.16% (Interest Expense 132.4m / Debt 2.57b)
Taxrate = 18.32% (204.6m / 1.12b)
NOPAT = 1.02b (EBIT 1.25b * (1 - 18.32%))
Current Ratio = 2.72 (Total Current Assets 2.73b / Total Current Liabilities 1.00b)
Debt / Equity = 0.52 (Debt 2.57b / totalStockholderEquity, last quarter 4.95b)
Debt / EBITDA = 1.59 (Net Debt 2.33b / EBITDA 1.47b)
Debt / FCF = 2.26 (Net Debt 2.33b / FCF TTM 1.03b)
Total Stockholder Equity = 4.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.18% (Net Income 847.7m / Total Assets 9.94b)
RoE = 18.30% (Net Income TTM 847.7m / Total Stockholder Equity 4.63b)
RoCE = 17.43% (EBIT 1.25b / Capital Employed (Equity 4.63b + L.T.Debt 2.54b))
RoIC = 11.74% (NOPAT 1.02b / Invested Capital 8.70b)
WACC = 8.98% (E(41.4b)/V(44.0b) * Re(9.28%) + D(2.57b)/V(44.0b) * Rd(5.16%) * (1-Tc(0.18)))
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.83 | Cagr: 0.38%
[DCF] Terminal Value 75.94% ; FCFF base≈931.1m ; Y1≈1.07b ; Y5≈1.57b
[DCF] Fair Price = 342.9 (EV 21.3b - Net Debt 2.33b = Equity 18.9b / Shares 55.2m; r=8.98% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.77 | EPS CAGR: 30.83% | SUE: 1.52 | # QB: 7
Revenue Correlation: 98.76 | Revenue CAGR: 19.94% | SUE: 1.42 | # QB: 2
EPS current Quarter (2027-01-31): EPS=1.61 | Chg30d=+2.42% | Revisions=+70% | Analysts=11
EPS current Year (2026-10-31): EPS=6.33 | Chg30d=+3.40% | Revisions=+86% | GrowthEPS=+29.2% | GrowthRev=+20.2%
EPS next Year (2027-10-31): EPS=7.20 | Chg30d=+3.67% | Revisions=+86% | GrowthEPS=+13.7% | GrowthRev=+11.4%
[Analyst] Revisions Ratio: +94% (up=44, down=0)